Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
Sponsorship: Partisan Bill (Republican 1)
Status: (Introduced - Dead) 2015-05-15 - Referred to the Subcommittee on Health.
[HB2338 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| Introduced | 2015-05-20 | PDF | Link | View |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|
| No bill amendments currently on file for US Congress HB2338 |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|
| No supplemental documents for US Congress HB2338 currently on file. |
